Open Orphan plc changed its name to hVIVO plc on 26 October 2022, learn more
Asthma & COPD
Phase II-III Trials
Vaccine Phase II-III Trials
Field Trial Bio-logistics
Cell Based Assays
Compound Efficacy & VRM
Articles & Research
News & Media
Media Press Kit
Regulatory News & Email Alerts
Share Price Information
Events & Presentations
Environmental, Social & Governance
AIM Rule 26
07 Feb 2023
Accelerated regulatory pathways: Vaccines for tropical diseases
Other recent posts
The UK Regulatory Competitiveness in an ever changing world
Clinical research success during the COVID-19 pandemic The United Kingdom, with its rich history of clinical trials, has long been a preferred destination for conducting cutting-edge research. One of the...
Human Challenge Clinical Trials Factsheet
World leader in testing infectious and respiratory disease products using human challenge clinical trials. Read more to see the benefits of a human challenge trial and what human challenge models...
If you’re a potential customer, job seeker, health professional or an investor, find out how hVIVO can help you.